Conclusion ROS are the natural consequence of aerobic metabolism and are important for basic cellular functions, including proliferation, inflammation, apoptosis, and gene expression
There arent enough studies done in pregnant women to show the drug poses a risk to the fetus
Very common (may affect more than 1 in 10 people): Nausea Vomiting Diarrhoea Constipation Abdominal (stomach) pain Headache Tiredness (fatigue) Low blood sugar (hypoglycaemia) in people with type 2 diabetes Common (may affect up to 1 in 10 people): Low blood sugar in people without type 2 diabetes Dizziness Altered taste (dysgeusia) and altered skin sensation (dysaesthesia) Indigestion (dyspepsia), heartburn / acid reflux (GORD), gastritis, burping, wind (flatulence) and bloating Increased heart rate Gallstones (cholelithiasis) Kidney stones (urolithiasis) Hair loss Increased blood levels of amylase, lipase and bilirubin Diabetic retinopathy in people with type 2 diabetes Hip fracture Uncommon to rare: Acute pancreatitis (inflammation of the pancreas) Low blood pressure (hypotension) and orthostatic hypotension Allergic reactions, including anaphylactic reaction and angioedema (swelling) Delayed gastric emptying and, rarely, intestinal obstruction Non-arteritic anterior ischaemic optic neuropathy (NAION), a rare eye condition that can cause sudden loss of vision Serious side effects
This durability points to Revitas potential as an important new strategy for long-term metabolic health and a new path forward for patients seeking to stay off chronic drug therapy.
It provides deep, lasting hydration without any heaviness 2
Whilst caffeine is a central nervous system stimulant that affects adenosine receptors, semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that influences insulin secretion, glucagon suppression, and appetite regulation
